Literature DB >> 25243889

Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.

Jun Ishii1, Hanako Sato, Takuya Yazawa, Yukiko Shishido-Hara, Chie Hiramatsu, Yukio Nakatani, Hiroshi Kamma.   

Abstract

One-third of lung malignancies demonstrate a proneural/neuroendocrine phenotype or type of differentiation. However, it has not been clearly elucidated how proneural/neuroendocrine differentiation is controlled in lung cancers. We recently demonstrated that the POU3F2 gene plays a significant role in proneural/neuroendocrine differentiation of lung cancers. Because class III POU genes (POU3F1, POU3F2, POU3F3, and POU3F4) and class IV POU genes (POU4F1, POU4F2, and POU4F3) share similar properties in neural development, we analyzed the association between class III/IV POU genes and a proneural/neuroendocrine phenotype in lung cancers using seven small cell lung cancer (SCLC) cell lines and twelve non-SCLC (NSCLC) cell lines. Class III/IV POU gene expression was generally restricted to SCLC cells. However, the forced expression of class III/IV POU genes in the NSCLC cell lines induced the expression of neuroendocrine-specific markers (neural call adhesion molecule 1, synaptophysin, and chromogranin A) and proneural transcription factors (achaete-scute homolog-like 1, NeuroD1, and thyroid transcription factor 1) in various degrees. Furthermore, each class III/IV POU gene induced other class III/IV POU genes, suggesting the mutual induction of class III/IV POU genes. These findings suggest that the expression of class III/IV POU genes is important for the proneural/neuroendocrine differentiation of lung cancer cells.
© 2014 Japanese Society of Pathology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  POU transcription factor; neuroendocrine differentiation; proneural differentiation; small cell lung cancer

Mesh:

Substances:

Year:  2014        PMID: 25243889     DOI: 10.1111/pin.12198

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  7 in total

1.  Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.

Authors:  Takashi Sato; Seungyeul Yoo; Ranran Kong; Abhilasha Sinha; Prashanth Chandramani-Shivalingappa; Ayushi Patel; Maya Fridrikh; Osamu Nagano; Takashi Masuko; Mary Beth Beasley; Charles A Powell; Jun Zhu; Hideo Watanabe
Journal:  Cancer Res       Date:  2019-09-24       Impact factor: 12.701

2.  Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

Authors:  Antonio García Escudero; Enrique Rodríguez Zarco; Juan Carlos Girón Arjona; María José Ríos Moreno; Katherine Gallardo Rodríguez; Ana Vallejo Benítez; Ricardo González Cámpora
Journal:  Virchows Arch       Date:  2016-06-14       Impact factor: 4.064

3.  BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2.

Authors:  Divya Bhagirath; Thao Ly Yang; Z Laura Tabatabai; Shahana Majid; Rajvir Dahiya; Yuichiro Tanaka; Sharanjot Saini
Journal:  Clin Cancer Res       Date:  2019-08-01       Impact factor: 12.531

4.  Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.

Authors:  Benjiao Gong; Yanlei Kao; Chenglin Zhang; Fudong Sun; Zhaohua Gong; Jian Chen
Journal:  Mediators Inflamm       Date:  2020-04-09       Impact factor: 4.711

5.  Comprehensive genetic analysis of histological components of combined small cell carcinoma.

Authors:  Yuko Iida; Yoko Nakanishi; Tetsuo Shimizu; Masayuki Nomoto; Yoshiko Nakagawa; Reiko Ito; Noriaki Takahashi; Shinobu Masuda; Yasuhiro Gon
Journal:  Thorac Cancer       Date:  2022-07-11       Impact factor: 3.223

6.  The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.

Authors:  Varune Rohan Ramnarine; Mohammed Alshalalfa; Fan Mo; Noushin Nabavi; Nicholas Erho; Mandeep Takhar; Robert Shukin; Sonal Brahmbhatt; Alexander Gawronski; Maxim Kobelev; Mannan Nouri; Dong Lin; Harrison Tsai; Tamara L Lotan; R Jefferey Karnes; Mark A Rubin; Amina Zoubeidi; Martin E Gleave; Cenk Sahinalp; Alexander W Wyatt; Stanislav V Volik; Himisha Beltran; Elai Davicioni; Yuzhuo Wang; Colin C Collins
Journal:  Gigascience       Date:  2018-06-01       Impact factor: 6.524

7.  Transcriptional characterization of conjunctival melanoma identifies the cellular tumor microenvironment and prognostic gene signatures.

Authors:  Julian Wolf; Claudia Auw-Haedrich; Anja Schlecht; Stefaniya Boneva; Hans Mittelviefhaus; Thabo Lapp; Hansjürgen Agostini; Thomas Reinhard; Günther Schlunck; Clemens A K Lange
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.